Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET

NeuroImage

Volumn 55, Issue 3, 2011, Pages 933-941

  Rosario, Bedda L ^a   Weissfeld, Lisa A ^b   Laymon, Charles M ^a   Mathis, Chester A ^a   Klunk, William E ^c   Berginc, Michael D ^a   James, Jeffrey A ^a   Hoge, Jessica A ^a   Price, Julie C ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atrophy correction; Automated delineation; Intra class correlation coefficient; Manual delineation; Partial volume correction; PET; PiB; Region of interest; Reliability

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ADULT; AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERRATER RELIABILITY; MALE; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; ANILINE COMPOUNDS; ATROPHY; BRAIN; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; THIAZOLES;

EID: 79952071915     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.12.070     Document Type: Article

References (40)

1. Aizenstein H.J., Nebes R.D., Saxton J.A., Price J.C., Mathis C.A., Tsopelas N.D., Ziolko S.K., James J.A., Snitz B.E., Houck P.R., Bi W., Cohen A.D., Lopresti B.J., DeKosky S.T., Halligan E.M., Klunk W.E. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 2008, 65(11):1509-1517.
2. Ashburner J., Friston K.J. Nonlinear spatial normalization using basis functions. Hum. Brain Mapp. 1999, 7(4):254-266.
3. Ashburner J., Friston K.J. Unified segmentation. Hum. NeuroImage 2005, 26:839-851.
4. Bailer U.F., Frank G.K., Henry S.E., Price J.C., Meltzer C.C., Mathis C.A., Wagner A., Thornton L., Hoge J., Ziolko S.K., Becker C.R., McConaha C.W., Kaye W.H. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol. Psychiatry 2007, 61:1090-1099.
5. Cohen A.D., Price J.C., Weissfeld L.A., James J., Rosario B.L., Bi W., Nebes R.D., Saxton J.A., Snitz B.E., Aizenstein H.J., Wolk D.A., DeKosky S.T., Mathis C.A., Klunk W.E. Basal cerebral metabolism may modulate the cognitive effects of a beta in mild cognitive impairment: an example of brain reserve. J. Neurosci. 2009, 29(47):14770-14778.
6. Fisher P.M., Meltzer C.C., Price J.C., Coleman R.L., Ziolko S.K., Becker C., Moses-Kolko E., Berga S.L., Hariri A.R. Medial prefrontal cortex 5-HT2A density is correlated with amygdala reactivity, response habituation and functional coupling. Cereb. Cortex 2009, 19(11):2499-2507.
7. Folstein M., Folstein S., McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
8. Jagust W.J., Landau S.M., Shaw L.M., Trojanowski J.Q., Koeppe R.A., Reiman E.M., Foster N.L., Petersen R.C., Weiner M.W., Price J.C., Mathis C.A. Relationships between biomarkers in aging and dementia. Neurology 2009, 73:1193-1199. For the Alzheimer's Disease Neuroimaging Initiative.
9. Jagust W.J., Bandy D., Chen K., Foster N.L., Landau S.M., Mathis C.A., Price J.C., Reiman E.M., Skovronsky D., Koeppe R.A., Alzheimer's Disease Neuroimaging Initiative The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's Dement 2010, 6:221-229.
10. 11C]PIB uptake is increased in mild cognitive impairment. Neurology 2007, 68:1603-1606.
11. Kiebel S.J., Ashburner J., Poline J., Friston K.J. MRI and PET coregistration - a cross validation of statistical parametric mapping and automated image registration. Neuroimage 1997, 5:271-279.
12. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55(3):306-319.
13. Lindgren K.A., Larson C.L., Schaefer S.M., Abercrombie H.C., Ward R.T., Oakes T.R., Holden J.E., Perlman S.B., Benca R.M., Davidson R.J. Thalamic metabolic rate predicts eeg alpha power in healthy control subjects but not in depressed patients. Biol. Psychiatry 1999, 45(8):934-952.
14. 11C-methyl-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
15. Lopresti B.J., Klunk W.E., Mathis C.A., Hoge J.A., Ziolko S.K., Lu X., Meltzer C.C., Schimmel K., Tsopelas N.D., DeKosky S.T., Price J.C. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J. Nucl. Med. 2005, 46(12):1959-1972.
16. McGraw K.O., Wong S.P. Forming inferences about some intraclass correlation coefficients. Psychol. Meth. 1996, 1(1):30-46.
17. McNamee R.L., Yee S., Price J.C., Klunk W.E., Rosario B., Weissfeld L., Ziolko S., Berginc M., Lopresti B., DeKosky S., Mathis C.A. Consideration of optimal time window for Pittsburgh Compound B PET summed uptake measurements. J. Nucl. Med. 2009, 50:348-355.
18. Meltzer C.C., Leal J.P., Mayberg H.S., Wagner H.N., Frost J.J. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J. Comput. Assist. Tomogr. 1990, 14(4):561-570.
19. Meltzer C.C., Kinahan P.E., Greer P.J., Nichols T.E., Comtat C., Cantwell M.N., Lin M.P., Price J.C. Comparative evaluation of MR-based partial-volume correction schemes for PET. J. Nucl. Med. 1999, 40:2053-2065.
20. Meltzer C.C., Cantwell M.N., Greer P., Ben-Eliezer D., Smith G.S., Frank G., Kaye W., Houck P.R., Price J.C. Does cerebral blood flow decline in healthy aging? A PET study with partial volume correction. J. Nucl. Med. 2000, 48(11):1842-1848.
21. Minoshima S., Frey K.A., Foster N.L., Kuhl D.E. An automated method for rotational correction and centering of three-dimensional functional images. J. Nucl. Med. 1992, 33:1579-1585.
22. 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67(3):446-452.
23. Morris J.C., Roe C.M., Xiong C., Fagan A.M., Goate A.M., Holtzman D.M., Mintun M.A. APOE predicts A? but not Tau Alzheimer's pathology in cognitively normal aging. Ann. Neurol. 2010, 67:122-131.
24. Nichols L., Pike V.W., Cai L., Innis R.B. Imaging and in vivo quantification of β-amyloid: an exemplary biomarker for Alzheimer's Disease?. Biol. Psychiatry 2006, 59:940-947.
25. Pike K.E., Savage G., Villemagne V.L., Ng S., Moss S.A., Maruff P., Mathis C.A., Klunk W.E., Masters C.L., Rowe C.C. β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007, 130(11):2837-2844.
26. Price J.C., Klunk W.E., Lopresti B.J., Lu X., Hoge J.A., Ziolko S.K., Holt D.P., Meltzer C.C., DeKosky S.T., Mathis C.A. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow Metab. 2005, 25:1528-1547.
27. Rosario B.L., Ziolko S.K., Weissfeld L.A., Price J.C. Assessment of parameter settings for SPM5 spatial normalization of structural MRI data: application to type 2 diabetes. Neuroimage 2008, 41(2):363-370.
28. Rowe C.C., Ackermann U., Gong S.J., Pike K., Savage G., Cowie T.F., Dickinson K.L., Maruff P., Darby D., Smith C., Woodward M., Merory J., Tochom-Danguy H., O'Keefe G., Klunk W.E., Mathis C.A., Price J.C., Masters C.L., Villemagne V.L. Imaging β-amyloid burden in aging and dementia. Neurology 2007, 68(20):1718-1725.
29. Rusjan P., Mamo D., Ginovart N., Hussey D., Vitcu I., Yasuno F., Tetsuya S., Houle S., Kapur S. An automated method for the extraction of regional data from PET images. Psychiatr. Res. Neuroimaging 2006, 147:79-89.
30. Schaefer S.M., Abercrombie H.C., Lindgren K.A., Larson C.L., Ward R.T., Oakes T.R., Holden J.E., Perlman S.B., Turski P.A., Davidson R.J. Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures. Hum. Brain Mapp. 2000, 10:1-9.
31. Shrout P.E. Measurement reliability and agreement in psychiatry. Stat. Methods Med. Res. 1998, 7(3):301-317.
32. Shrout P.E., Fleiss J.L. Intraclass correlations: uses in assessing reliability. Psychol. Bull. 1979, 86:420-428.
33. Small G.W., Stern C.E., Mandelkern M.A., Fairbanks L.A., Min C.A., Guze B.H. Reliability of drawing regions of interest for positron emission tomographic data. Psychiatry Res. Neuroimaging 1992, 45(3):177-185.
34. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbol S., Frokjaer V.G., Holm S., Paulson O.B., Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005, 24:969-979.
35. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
36. West J., Fitzpatrick J.M., Wang M.Y., Dawant B.M., Maurer C.R., Kessler R.M., Maciunas R.J., Barillot C., Lemoine D., Collignon A., Maes F., Suetens P., Vandermeulen D., van den Elsen P.A., Napel S., Sumanaweera T.S., Harkness B., Hemler P.F., Hill D.L.G., Hawkes D.J., Studholme C., Maintz J.B.A., Viergever M.A., Malandain G., Pennec X., Noz M.E., Maguire G.Q., Pollack M., Pelizzari C.A., Robb R.A., Hanson D., Woods R.P. Comparison and evaluation of retrospective intermodality image registration techniques. J. Comput. Assist. Tomogr. 1997, 21:554-566.
37. 11C]-6-OH-BTA-1). J. Labelled Comp. Radiopharm. 2004, 47:679-682.
38. Wolk D.A., Price J.C., Saxton J.A., Snitz B.E., James J.A., Lopez O.L., Aizenstein H.J., Weissfeld L.A., Mathis C.A., Klunk W.E., DeKosky S.T. Amyloid imaging in mild cognitive impairment subtypes. Ann. Neurol. 2009, 65(5):557-568.
39. Woods R.P., Mazziotta J.C., Cherry S.R. MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 1993, 17:536-546.
40. Yasuno F., Hasnine A.H., Suhara T., Ichimiya T., Sudo Y., Inoue M., Takano A., Ou T., Ando T., Toyama H. Template-based method for multiple volumes of interest of human brain PET images. Neuroimage 2002, 16:577-586.